Espona-Fiedler, M.; Manuel-Manresa, P.; BenÃtez-GarcÃa, C.; Fontova, P.; Quesada, R.; Soto-Cerrato, V.; Pérez-Tomás, R.
Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma. Pharmaceutics 2023, 15, 97.
https://doi.org/10.3390/pharmaceutics15010097
AMA Style
Espona-Fiedler M, Manuel-Manresa P, BenÃtez-GarcÃa C, Fontova P, Quesada R, Soto-Cerrato V, Pérez-Tomás R.
Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma. Pharmaceutics. 2023; 15(1):97.
https://doi.org/10.3390/pharmaceutics15010097
Chicago/Turabian Style
Espona-Fiedler, Margarita, Pilar Manuel-Manresa, Cristina BenÃtez-GarcÃa, Pere Fontova, Roberto Quesada, Vanessa Soto-Cerrato, and Ricardo Pérez-Tomás.
2023. "Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma" Pharmaceutics 15, no. 1: 97.
https://doi.org/10.3390/pharmaceutics15010097
APA Style
Espona-Fiedler, M., Manuel-Manresa, P., BenÃtez-GarcÃa, C., Fontova, P., Quesada, R., Soto-Cerrato, V., & Pérez-Tomás, R.
(2023). Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma. Pharmaceutics, 15(1), 97.
https://doi.org/10.3390/pharmaceutics15010097